18 Dec 2025

Shardul Amarchand Mangaldas Advises Medi Assist on INR 198 Crore Preferential Equity Fundraise

"Shardul Amarchand Mangaldas & Co. advised Medi Assist Healthcare Services Limited on an approximately INR 198 crore preferential issue of fully paid equity shares to Massachusetts Institute of Technology and 238 Plan Associates LLC. The investors, both qualified institutional buyers and SEBI-registered FPIs, now hold 3.86% and 1.08% of Medi Assist respectively. IIFL Capital Services Limited was the financial advisor."

Shardul Amarchand Mangaldas & Co. advised Medi Assist Healthcare Services Limited in a preferential equity fundraise that saw equity allotted to Massachusetts Institute of Technology and 238 Plan Associates LLC. New Delhi | 18th December 2025: The transaction comprised an approximately INR 198 crore fundraise by Medi Assist Healthcare Services Limited through a preferential issue of fully paid-up equity shares to the Investors. The allotment was made on a preferential basis to qualified institutional buyers who are SEBI-registered foreign portfolio investors. Following the Preferential Issue, Massachusetts Institute of Technology and 238 Plan Associates LLC hold 3.86% and 1.08%, respectively, of the total share capital of Medi Assist. IIFL Capital Services Limited acted as the financial advisor to the transaction. Shardul Amarchand Mangaldas & Co. represented client(s) Medi Assist Healthcare Services Limited with a team composed by: Prashant Gupta, National Practice Head – Capital Markets; Devesh Pandey, Partner; Jasmine Khan, Senior Associate; Anushka Ganguli, Associate; and Sourav Paul, Associate.
Read the full story

Register for free to access daily news.

Register Free